Microangiopathic haemolytic anaemia: the experimental production of haemolysis and red-cell fragmentation by defibrination in vivo.
D000614:Aminocaproates / Q000494:pharmacology; D000743:Anemia, Hemolytic / Q000503:physiopathology; D000818:Animals; D001772:Blood Cell Count; D004912:Erythrocytes / Q000503:physiopathology*; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis*; D005342:Fibrinolysis / Q000187:drug effects; D006452:Hemoglobinometry; D006461:Hemolysis / Q000187:drug effects*; D006493:Heparin / Q000494:pharmacology; D007456:Iodine Isotopes; D007503:Iron Isotopes; D008297:Male; D010949:Plasma / Q000032:analysis; D011817:Rabbits; D013927:Thrombosis / Q000473:pathology; D014361:Trypsin Inhibitors / Q000494:pharmacology; D014688:Venoms / Q000494:pharmacology; D014859:Warfarin / Q000494:pharmacology
D000614:Aminocaproates; D007456:Iodine Isotopes; D007503:Iron Isotopes; D014361:Trypsin Inhibitors; D014688:Venoms; D014859:Warfarin; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin